Ziyad Al-Ali
Ziyad Al-Ali is the director of the Center for Clinical Epidemiology at the St. Louis Health Care System, recognized for his research on the effects of GLP-1 receptor agonists on addiction. His recent study analyzed data from over 606,000 veterans with Type 2 diabetes, revealing that patients using weight loss injections experienced significantly lower incidences of substance abuse compared to those on other diabetes medications.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Switzerland | 1 | 8.00 | 0.36% | +0% | 8,654,622 | 30,909 | $700,000 | 2,500$ |
| Totals | 1 | 8,654,622 | 30,909 | $700,000 | 2,500$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
Ziyad Al-Ali is the director of the Center for Clinical Epidemiology at the St. Louis Health Care System and led a study analyzing data from over 606,000 veterans.
8